2011
DOI: 10.5354/0717-3652.2011.16702
|View full text |Cite
|
Sign up to set email alerts
|

Implementación de la Política Nacional de Medicamentos de la Reforma de la Salud: percepción del profesional farmacéutico

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
0
1
0
1
Order By: Relevance
“…The policy was proposed to the institutions involved in pharmaceutical logistic (from the production to the patient's use) and incorporated directives to change the role of pharmacists and pharmacies. However, these efforts have been partially implemented, as reflected by the pharmacists who have not seen significant changes, highlighting the economic perspective on health policy [26].…”
Section: Pharmaceutical Policy In Chilementioning
confidence: 99%
“…The policy was proposed to the institutions involved in pharmaceutical logistic (from the production to the patient's use) and incorporated directives to change the role of pharmacists and pharmacies. However, these efforts have been partially implemented, as reflected by the pharmacists who have not seen significant changes, highlighting the economic perspective on health policy [26].…”
Section: Pharmaceutical Policy In Chilementioning
confidence: 99%
“…19 Existe evidencia respecto a que la implementación y resultados de la Reforma AU-GE-GES ha sido percibida por los diversos actores como un proceso fragmentado. [20][21][22][23] Por otra parte, hay información que apunta a que, si bien la garantía de acceso ha tenido una implementación exitosa, en la garantía de oportunidad ha existido incumplimiento importante para la solución de varias patologías, generando listas de espera no previstas ni legales. 24 En cuanto a la garantía de protección financiera, consistente en la fijación de copagos máximos para los beneficiarios, lo que se vislumbra como un instrumento a favor de la equidad, permaneciendo como el único aspecto deficitario la entrega no oportuna de algunos medicamentos de la canasta AUGE.…”
unclassified